Matches in SemOpenAlex for { <https://semopenalex.org/work/W2567417891> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W2567417891 abstract "Multiple Myeloma (MM) is a complex disease that frequently leads to fatal outcome and accurate risk classification to optimize the choice of therapy may have impact on clinical outcomes. MM stratification based upon cytogenetic abnormalities and protein-coding gene expression does not adequately correlate with the depth or durability of therapeutic response. Therefore, the new class of molecular effectors, non-coding RNAs (ncRNAs), may enhance the basic understanding of myelomagenesis, drug resistance and provide better stratification of myeloma subtypes. NcRNAs include long ncRNAs (lncRNAs) and microRNAs (miRNAs) that may act as positive or negative regulators of gene expression to control cell proliferation, apoptosis and drug resistance. We hypothesized that lncRNAs commonly deregulated in the 3 resistant cell lines would have significant overlap to the deregulated lncRNA in MM patients. To investigate the role of lncRNAs in resistance to proteasome inhibitors (PIs), we compared global lncRNA profiling in drug-naive cells to cells with acquired resistance to the PIs bortezomib, carfilzomib and ixazomib. RPMI 8226 cells resistant to each of the three PIs were generated through successive exposure to bortezomib, carfilzomib or ixazomib. Total RNA was isolated and genome-wide ncRNA expression profiling was performed using Affymetrix 3.0 microarray chips LncRNA expression profiles from drug-resistant cells were compared to that of drug-naive cells treated with vehicle alone. MM patients’ bone marrow aspirates were obtained after UCCOM IRB-approval. Bioinformatic analysis identified a panel of 18 lncRNAs that were significantly (>100-fold) deregulated in all three drug-resistant cell lines relative to drug-naive cells. Strikingly, the majority of the deregulated lncRNAs exhibited a similar expression pattern in all 3 PI-resistant cell lines (Figure 2a). RPMI 8226 cells carry a t(14,16) and none of the deregulated lncRNAs detected localized to chromosomes 14 or 16, suggestive of a cytogenetic-independent mechanism of drug resistance. We also identified lncRNAs deregulated in MM patient samples relative to plasma cells from healthy age-matched individuals. We found a significant overlap (>90%) between deregulated lncRNAs in PI-resistant cells and MM cells. The lncRNA COL4A-2A was upregulated >5,000-fold in resistant cells and displayed extensive sequence complementarity to miRNA-29 that was downregulated in resistant cells. Taken together, we identified a curated panel of deregulated lncRNAs in common within myeloma cells generated with acquired resistant to three different clinically-relevant proteasome inhibitors and MM patients. Further investigation is warranted to shed light on the role of these lncRNAs in the development of MM, to identify their targets and to define their role in drug resistance. Note: This abstract was not presented at the meeting. Citation Format: Ehsan Malek, Rebekah Karns, Anil G. Jegga, Sajjeev Jagannathan, Nikhil Vad, Mohamed A.Y Abdel Malek, James J. Driscoll. Long non-coding RNAs deregulated in Multiple Myeloma impact therapeutic response to proteasome inhibitors. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 153. doi:10.1158/1538-7445.AM2015-153" @default.
- W2567417891 created "2017-01-06" @default.
- W2567417891 creator A5000907656 @default.
- W2567417891 creator A5005848743 @default.
- W2567417891 creator A5030119098 @default.
- W2567417891 creator A5035898667 @default.
- W2567417891 creator A5061689835 @default.
- W2567417891 creator A5083283435 @default.
- W2567417891 creator A5089781611 @default.
- W2567417891 date "2015-08-01" @default.
- W2567417891 modified "2023-09-26" @default.
- W2567417891 title "Abstract 153: Long non-coding RNAs deregulated in Multiple Myeloma impact therapeutic response to proteasome inhibitors" @default.
- W2567417891 doi "https://doi.org/10.1158/1538-7445.am2015-153" @default.
- W2567417891 hasPublicationYear "2015" @default.
- W2567417891 type Work @default.
- W2567417891 sameAs 2567417891 @default.
- W2567417891 citedByCount "1" @default.
- W2567417891 countsByYear W25674178912016 @default.
- W2567417891 crossrefType "proceedings-article" @default.
- W2567417891 hasAuthorship W2567417891A5000907656 @default.
- W2567417891 hasAuthorship W2567417891A5005848743 @default.
- W2567417891 hasAuthorship W2567417891A5030119098 @default.
- W2567417891 hasAuthorship W2567417891A5035898667 @default.
- W2567417891 hasAuthorship W2567417891A5061689835 @default.
- W2567417891 hasAuthorship W2567417891A5083283435 @default.
- W2567417891 hasAuthorship W2567417891A5089781611 @default.
- W2567417891 hasConcept C104317684 @default.
- W2567417891 hasConcept C114851261 @default.
- W2567417891 hasConcept C145059251 @default.
- W2567417891 hasConcept C150194340 @default.
- W2567417891 hasConcept C18431079 @default.
- W2567417891 hasConcept C186836561 @default.
- W2567417891 hasConcept C194993378 @default.
- W2567417891 hasConcept C203014093 @default.
- W2567417891 hasConcept C27740335 @default.
- W2567417891 hasConcept C2776364478 @default.
- W2567417891 hasConcept C2777478702 @default.
- W2567417891 hasConcept C2778367456 @default.
- W2567417891 hasConcept C2780108899 @default.
- W2567417891 hasConcept C2781098529 @default.
- W2567417891 hasConcept C502942594 @default.
- W2567417891 hasConcept C54355233 @default.
- W2567417891 hasConcept C62203573 @default.
- W2567417891 hasConcept C67705224 @default.
- W2567417891 hasConcept C71924100 @default.
- W2567417891 hasConcept C86803240 @default.
- W2567417891 hasConceptScore W2567417891C104317684 @default.
- W2567417891 hasConceptScore W2567417891C114851261 @default.
- W2567417891 hasConceptScore W2567417891C145059251 @default.
- W2567417891 hasConceptScore W2567417891C150194340 @default.
- W2567417891 hasConceptScore W2567417891C18431079 @default.
- W2567417891 hasConceptScore W2567417891C186836561 @default.
- W2567417891 hasConceptScore W2567417891C194993378 @default.
- W2567417891 hasConceptScore W2567417891C203014093 @default.
- W2567417891 hasConceptScore W2567417891C27740335 @default.
- W2567417891 hasConceptScore W2567417891C2776364478 @default.
- W2567417891 hasConceptScore W2567417891C2777478702 @default.
- W2567417891 hasConceptScore W2567417891C2778367456 @default.
- W2567417891 hasConceptScore W2567417891C2780108899 @default.
- W2567417891 hasConceptScore W2567417891C2781098529 @default.
- W2567417891 hasConceptScore W2567417891C502942594 @default.
- W2567417891 hasConceptScore W2567417891C54355233 @default.
- W2567417891 hasConceptScore W2567417891C62203573 @default.
- W2567417891 hasConceptScore W2567417891C67705224 @default.
- W2567417891 hasConceptScore W2567417891C71924100 @default.
- W2567417891 hasConceptScore W2567417891C86803240 @default.
- W2567417891 hasLocation W25674178911 @default.
- W2567417891 hasOpenAccess W2567417891 @default.
- W2567417891 hasPrimaryLocation W25674178911 @default.
- W2567417891 hasRelatedWork W2022238846 @default.
- W2567417891 hasRelatedWork W2165676118 @default.
- W2567417891 hasRelatedWork W2234171363 @default.
- W2567417891 hasRelatedWork W2361928047 @default.
- W2567417891 hasRelatedWork W2506116659 @default.
- W2567417891 hasRelatedWork W2515810216 @default.
- W2567417891 hasRelatedWork W2524598886 @default.
- W2567417891 hasRelatedWork W2560960439 @default.
- W2567417891 hasRelatedWork W2563416939 @default.
- W2567417891 hasRelatedWork W2566885249 @default.
- W2567417891 hasRelatedWork W2588913130 @default.
- W2567417891 hasRelatedWork W2591703592 @default.
- W2567417891 hasRelatedWork W2886531639 @default.
- W2567417891 hasRelatedWork W2904037458 @default.
- W2567417891 hasRelatedWork W2971518777 @default.
- W2567417891 hasRelatedWork W2981222059 @default.
- W2567417891 hasRelatedWork W3012847158 @default.
- W2567417891 hasRelatedWork W3158471822 @default.
- W2567417891 hasRelatedWork W3211883867 @default.
- W2567417891 hasRelatedWork W3212854229 @default.
- W2567417891 isParatext "false" @default.
- W2567417891 isRetracted "false" @default.
- W2567417891 magId "2567417891" @default.
- W2567417891 workType "article" @default.